Takara Bio Chinese Subsidiary To Expand Lines Of Business, Files Chinese Clinical Trial Application

Tokyo, Mar 30, 2006 (JCN) - Takara Bio announced on March 28 that its subsidiary, Takara Biomedical Technology (Beijing), has received approval from the Chinese Ministry of Commerce for an expansion of its lines of business, namely the import and wholesaling of reagents for biological research and laboratory equipment.

MORE ON THIS TOPIC